Abstract:Objective: To explore the association between ANRIL promoter methylation level and coronary artery disease development. Subject and method: The methylation status of ANRIL promote in 100 subjects with coronary artery disease patients and matched controls who underwent coronary angiography was quantitatively analyzed on Sequenom MassARRAY. KEGG pathway enrichment analyses were performed to identify the functions and pathways possibly influenced by the genes nearest the ANRIL promoter CpG sites in subjects with CAD compared with the controls. Result: Results indicate 7 to 8 CpG sites within the 2nd CpG island located at the upstream of CDKN2B-AS1 is hyper-methylated in CADs compared with the matched controls (p=0.034), 40th CpG sites within the 2nd CpG island located at the upstream of CDKN2B-AS1 is lower-methylated in CADs compared with the matched controls (p=0.045). The Pearson or Spearman analyses indicated that methylation level of 7 to 8 CpG sites within the 2nd CpG island was significantly associated with TCH (r=-0.204, p=0.004), HDL-C (r=0.165, p=0.020), and LDL-C (r=0.265, p=0.000), and the methylation level of 40th CpG sites within the 2nd CpG island was significantly associated with age (r=-0.147, p=0.037) and fasting blood glucose (r=-0.178, p=0.012). KEGG pathway analysis revealed a significant enrichment of genes associated with the TNF signaling pathway. Among them, the C/EBPbeta was identified as key transcription factor to promote the expression of CDKN2B-AS1 through interaction with theirÂ promoters. Conclusion: Expression levels of the ANRIL promoter DNA methylation were significantly associated with the CAD development in this population. Further KEGG pathway enrichment analyses suggested that C/EBPbeta has been identified as key transcription factor to promote the expression of CDKN2B-AS1 through interaction with their promoters via TNF signaling pathway. Funding Statement: the National Natural Science Foundation of China (grantsNo. 30400173, 30971257, and 81170180) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. Declaration of Interests: There was not any conflict of interest existing in this manuscript. Ethics Statement: The study was performed based on the case-control principle in accordance with the protocol approved by the ethics committee of the First Affiliated Hospital of Nanjing Medical University and the Friendship Hospital of Ili Kazakh Autonomous Prefecture in China.

Analysis of ANRIL Isoforms and Key Genes in Patients with Severe Coronary Artery Disease

Multiple Non-coding ANRIL Transcripts Are Associated with Risk of Coronary Artery Disease: a Promising Circulating Biomarker

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

Correction: Long Noncoding RNA ANRIL Regulates Endothelial Cell Activities Associated with Coronary Artery Disease by Up-Regulating CLIP1, EZR, and LYVE1 Genes.

Associations between low serum levels of ANRIL and some common gene SNPs in Iranian patients with premature coronary artery disease

Effect of Circular ANRIL on the Inflammatory Response of Vascular Endothelial Cells in a Rat Model of Coronary Atherosclerosis

[Research Advance of ANRIL on Atherosclerosis by Regulating Cell Proliferation and Apoptosis].

ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease

The Lncrna ANRIL Regulates Endothelial Dysfunction by Targeting the Let‐7b/tgf‐βr1 Signalling Pathway

Long Non-Coding RNA ANRIL Regulates Inflammatory Responses As a Novel Component of NF-κB Pathway.

The Interplay of LncRNA ANRIL and Mir‐181b on the Inflammation‐relevant Coronary Artery Disease Through Mediating NF‐κB Signalling Pathway

ANRIL's Epigenetic Regulation and Its Implications for Cardiovascular Disorders

Long Noncoding RNA ANRIL: a Potential Novel Prognostic Marker in Cancer: a Meta-Analysis.

Relationship Between DNA Methylation in Long Non-Coding RNA ANRIL and Coronary Artery Disease

Variants in ANRIL gene correlated with its expression contribute to myocardial infarction risk.

Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans

Splice Variants of Lncrna RNA ANRIL Exert Opposing Effects on Endothelial Cell Activities Associated with Coronary Artery Disease

DNA Methylation of Antisense Noncoding RNA in the INK Locus (ANRIL) is Associated with Coronary Artery Disease in a Chinese Population

Long noncoding RNA ANRIL knockdown attenuates neuroinflammation following ischemic stroke via suppressing the expression of NF-κB in vitro and in vivo

Long Noncoding RNA ANRIL As a Novel Biomarker of Lymph Node Metastasis and Prognosis in Human Cancer: a Meta-Analysis

LncRNA ANRIL Facilitates Vascular Smooth Muscle Cell Proliferation and Suppresses Apoptosis via Modulation of miR-7/FGF2 Pathway in Intracranial Aneurysms